APX005M

· Apexigen

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for APX005M, covering 2022-08-11 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma [Phase 1, Phase 2]